NVIV

InVivo Therapeutics Holdings Corp
NVIV

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

4 hedge funds and large institutions have $5.22K invested in InVivo Therapeutics Holdings Corp in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$5.22K

Top Sellers

1
-$25.3K
2
-$22.8K
3
-$13.6K
4
TRCT
Tower Research Capital (TRC)
New York
-$6.13K
5
Morgan Stanley
Morgan Stanley
New York
-$394
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$5.22K
VL
2
Vima LLC
Michigan
$2
BlackRock
3
BlackRock
New York
–
Vanguard Group
4
Vanguard Group
Pennsylvania
–
Geode Capital Management
5
Geode Capital Management
Massachusetts
–
TRCT
6
Tower Research Capital (TRC)
New York
–
Morgan Stanley
7
Morgan Stanley
New York
–
Wells Fargo
8
Wells Fargo
California
–
Osaic Holdings
9
Osaic Holdings
Arizona
–
ITIM
10
Indiana Trust & Investment Management
Indiana
–
CTA
11
Colonial Trust Advisors
South Carolina
–
AF
12
Allworth Financial
California
–
PWA
13
Provenance Wealth Advisors
Florida
–
UBS Group
14
UBS Group
Switzerland
–